HCW Biologics
Miramar Beach
About HCW Biologics
HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $85.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nasdaq:HCWB
- Website: hcwbiologics.com
- Phone: (954) 842-2024
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/hcw-biologics-71191 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.